Satoshi Ikeda
Kanagawa Cardiovascular and Respiratory Center
Health Care Professional, Medicine And Medical Sciences
Japan
My co-authors include
Dr Tiago M Alfaro
Dr Giovanni Ferrara
Dr Anoop M Nambiar
Find me at
My Publications
Clinical characteristics of Japanese patients with moderate to severe COVID-19
Journal of Infection and Chemotherapy
June 2021
ICI for NSCLC with comorbid IP; a prudent stance required
European Journal of Cancer
May 2021
Beneficial impact of weight loss on respiratory function in interstitial lung disease p...
Respiratory Investigation
March 2021
Predictive factors for the long-term use of pirfenidone in patients with fibrosing inte...
Respiratory Investigation
February 2021
Real‐world efficacy of atezolizumab in non‐small cell lung cancer: A multicenter cohort...
Thoracic Cancer
January 2021
Identification and Characteristics of Co-isolation of Multiple Nontuberculous Mycobacteria
Internal Medicine
January 2021
Corticosteroids for hospitalized patients with mild to critically-ill COVID-19: A multi...
November 2020
Pneumothorax in a COVID-19 Pneumonia Patient without Underlying Risk Factors
Internal Medicine
November 2020
Unilateral upper lung-field pulmonary fibrosis radiologically consistent with pleuropar...
Respiratory Investigation
November 2020
Evaluation of lymphocytic infiltration in the bronchial glands of Sjögren’s syndrome in...
BMC Pulmonary Medicine
October 2020
Ramucirumab or placebo plus erlotinib in EGFR ‐mutated, metasta...
Cancer Science
October 2020
Tolerability and safety of nintedanib in elderly patients with idiopathic pulmonary fib...
Respiratory Investigation
September 2020
Phase I/II study of carboplatin plus weekly nab-paclitaxel in patients aged ≥75 years w...
Lung Cancer
August 2020
Atezolizumab for pretreated NSCLC with idiopathic interstitial pneumonias
Journal of Thoracic Oncology
August 2020
Outcome of early-stage combination treatment with favipiravir and methylprednisolone fo...
Respiratory Investigation
August 2020
Importance of doctor‐initiated management of the balance between work and treatment for...
Cancer Medicine
July 2020
Small‑cell lung carcinoma transformation of lung adenocarcinoma diagnosed by pericardia...
Molecular and Clinical Oncology
June 2020
Miliary lung metastases from ROS1‑rearranged lung adenocarcinoma: A case report
Molecular and Clinical Oncology
May 2020
Treatment rationale and design of a phase III study of Afatinib or CHemotherapy In pati...
Clinical Lung Cancer
May 2020
Anterior mediastinal amyloidosis mimics thymic carcinoma
JTO Clinical and Research Reports
April 2020
A phase II study of atezolizumab for pretreated advanced/recurrent non-small cell lung ...
Therapeutic Advances in Medical Oncology
January 2020
Rationale and protocol design for the TORG1835/NEXT-SHIP study: a phase II study of car...
Therapeutic Advances in Medical Oncology
January 2020
Phase II study of atezolizumab for pretreated advanced / recurrent non-small cell lung ...
Annals of Oncology
November 2019
Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small...
The Lancet Oncology
October 2019
Erdheim‐Chester disease progression from miliary pulmonary nodules to large tumours
Respirology Case Reports
August 2019
A Phase II Study of Cisplatin Plus Gemcitabine followed by Maintenance Gemcitabine for ...
Oncology
August 2019
Summary of the Japanese Respiratory Society statement for the treatment of lung cancer ...
Respiratory Investigation
August 2019
Negative impact of anorexia and weight loss during prior pirfenidone administration on ...
BMC Pulmonary Medicine
April 2019
Evaluation of changes in the serum levels of Krebs von den Lungen-6 and surfactant prot...
Respiratory Investigation
April 2019
Rapid effect of osimertinib re‑challenge on brain metastases developing during salvage ...
Molecular and Clinical Oncology
February 2019
Pulmonary Follicular Lymphoma Showing Diffuse Micronodules Mimicking Sarcoidosis
Internal Medicine
February 2019
Low starting-dosage of nintedanib for the reduction of early termination
Respiratory Investigation
February 2019
Pemetrexed-induced Interstitial Lung Disease Mimicking Hypersensitivity Pneumonia: A Pa...
Internal Medicine
January 2019
Miliary lung metastases from non‑small cell lung cancer with Exon 20 insertion: A disma...
Molecular and Clinical Oncology
October 2018
ASP8273 tolerability and antitumor activity in tyrosine kinase inhibitor-naïve Japanese...
Cancer Science
June 2018
Predictive Factors for the Long-Term Deterioration of Pulmonary Function in Interstitia...
Respiration
May 2018
Secondary pulmonary alveolar proteinosis predominant in the transplanted lung in patien...
Journal of Thoracic Disease
May 2018
Prognostic factors and disease behaviour of pathologically proven fibrotic non-specific...
Respirology
April 2018
Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as...
BMC Cancer
March 2018
Emphysematous change with scleroderma-associated interstitial lung disease: the potenti...
BMC Pulmonary Medicine
January 2018
Isolated Brain Metastases as the First Relapse After the Curative Surgical Resection in...
Clinical Lung Cancer
January 2018
Serum albumin level as a potential marker for deciding chemotherapy or best supportive ...
BMC Cancer
November 2017
Low body surface area predicts hepatotoxicity of nintedanib in patients with idiopathic...
Scientific Reports
September 2017
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an intern...
European Respiratory Journal
August 2017
Serum KL-6 and surfactant protein-D as monitoring and predictive markers of interstitia...
Journal of Thoracic Disease
February 2017
Unilateral Upper Lung Field Pulmonary Fibrosis Radiologically Consistent with Pleuropar...
Respiration
January 2017
A case of relapsed lung abscess caused by Eubacterium brachy infection following an ini...
Respiratory Medicine Case Reports
January 2017
Hepatotoxicity of nintedanib in patients with idiopathic pulmonary fibrosis: A single-c...
Respiratory Investigation
January 2017
A 16-year Follow-up Case of Interstitial Pneumonia with Systemic Sclerosis-rheumatoid A...
Internal Medicine
January 2017
Desquamative Interstitial Pneumonia Complicated with IgG4-related Lung Disease
Internal Medicine
January 2017
Abundant immunoglobulin (Ig)G4-positive plasma cells in interstitial pneumonia without ...
Histopathology
September 2016
Clinical Features of Idiopathic Interstitial Pneumonia with Systemic Sclerosis-Related ...
PLoS ONE
August 2016
Safety and efficacy of S-1 in combination with carboplatin in non-small cell lung cance...
Cancer Chemotherapy and Pharmacology
April 2016
Administration of nintedanib after discontinuation for acute exacerbation of idiopathic...
BMC Pulmonary Medicine
March 2016
Retroperitoneal Metastasis from Lung Adenocarcinoma Mimics Retroperitoneal Fibrosis
Journal of Thoracic Oncology
February 2016
Interstitial lung disease in clinically amyopathic dermatomyositis with and without ant...
BMC Pulmonary Medicine
December 2015
Clinical characteristics of pneumonia in bedridden patients receiving home care: A 3-ye...
Journal of Infection and Chemotherapy
August 2015
Incidence and impact of interstitial lung disease and malignancy in patients with polym...
SpringerPlus
May 2015
Chronological Assessment of Airway Lesions in Relapsing Polychondritis by Positron Emis...
Internal Medicine
January 2015
Identifying the Cause of the "Saturation Gap": Two Cases of Dapsone-induced Methemoglob...
Internal Medicine
January 2015
Interstitial lung disease induced by alectinib (CH5424802/RO5424802)
Japanese Journal of Clinical Oncology
November 2014
Clinical characteristics of severe community-acquired pneumonia among younger patients:...
Journal of Infection and Chemotherapy
August 2014
Diffuse Alveolar Hemorrhage as a Fatal Adverse Effect of Bevacizumab: An Autopsy Case
Japanese Journal of Clinical Oncology
March 2014
